Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?

MeSH terms

• Carcinoma, Hepatocellular / prevention & control*
• Carcinoma, Hepatocellular / virology
• Chronic Disease
• Cost-Benefit Analysis
• Hepatitis B / complications
• Hepatitis B / therapy*
• Humans
• Interferon alpha-2
• Interferon-alpha / economics
• Interferon-alpha / therapeutic use*
• Liver Cirrhosis / prevention & control*
• Liver Cirrhosis / virology
• Liver Neoplasms / prevention & control*
• Liver Neoplasms / virology
• Meta-Analysis as Topic
• Randomized Controlled Trials as Topic
• Recombinant Proteins